5Perry C,Eldor A,Soreg H. Runxl/AML1 in leukemia:disrupted association with diverse protein partners. Leuk Res, 2002,26:221- 228. 被引量：1
6Nguyen S,Leblanc T,Fenaux P,et al. A white blood cell index as the main prognostic factor in t (8;21) acute myeloid leukemia (AML) : a survey of 161 cases from the French AML Intergroup. Blood ,2002,99:3517-3523. 被引量：1
7Byrd JC,Dodge RK,Carroll A,et al. Patients with t(8;21 ) (q22; q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol, 1999,17:3767-3775. 被引量：1
8Tomizawa D, Tabuchi K, Kinoshita A, et al. Repetitive cycles of high-dose eytarabine are effective for childhood acute myeloid leukemia : long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children' s Cancer Study Group. Pediatr Blood Cancer,2007,49 : 127-132. 被引量：1
9Cahn JY, Labopin M, Sierra J, et al. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol,2000 ,110 :308-314. 被引量：1
10REESJ KH, GRAY RG, SWIRSKY D, et al. Principal results of the Medical Research Council' s 8th Acute Myeloid Leukaemia Trial[J]. Lancet, 1986, 2(8518) :1236-1241. 被引量：1
